feed,title,long_url,short_url
MedRxiv,Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study,https://medrxiv.org/cgi/content/short/2025.03.04.25323313v1?rss=1,https://da.gd/p3F1x
